# The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS

> **NCT02704871** · — · TERMINATED · sponsor: **Immunexpress** · enrollment: 66 (actual)

## Conditions studied

- Sepsis
- SIRS

## Interventions

- **OTHER:** SeptiCyte Lab molecular diagnostic test (non-interventional)

## Key facts

- **NCT ID:** NCT02704871
- **Lead sponsor:** Immunexpress
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2016-04
- **Final completion:** 2018-02
- **Target enrollment:** 66 (ACTUAL)
- **Why stopped:** Recruitment considerations only and not because of safety or outcomes issues
- **Last updated:** 2018-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02704871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02704871, "The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02704871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*